Our finding of reduced RBM3 expression being associated with advanced tumor stage in adenocarcinoma of the esophagus is supported by findings of Jonsson et al. [12] describing a significant association between reduced RBM3 expression and a more aggressive tumor phenotype. Here, RBM3 is linked to esophageal adenocarcinoma.